Tilray logo
Tilray TLRY
€ 6.33 0.0%

Quartalsbericht 2025-Q4
hinzugefügt 08.01.2026

report update icon

Tilray DIO 2011-2026 | TLRY

DIO Jährlich Tilray

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
170 179 164 107 207 205 - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
207 107 172

DIO Vierteljährlich Tilray

2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
161 166 - 180 161 168 - 163 151 149 - 129 219 214 107 195 181 198 97.7 463 88.9 101 - 203 - 227 238 269 - 212 266 276 - 278 148 - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
463 88.9 193

DIO anderer Aktien in der Arzneimittelhersteller

Name DIO Preis % 24h Marktkapitalisierung Land
AcelRx Pharmaceuticals AcelRx Pharmaceuticals
ACRX
133 - 7.5 % $ 6.35 M usaUSA
Aerie Pharmaceuticals Aerie Pharmaceuticals
AERI
459 - - $ 754 M usaUSA
Alimera Sciences Alimera Sciences
ALIM
58.7 - - $ 142 M usaUSA
Agile Therapeutics Agile Therapeutics
AGRX
82.7 - 10.11 % $ 58.2 M usaUSA
Adamis Pharmaceuticals Corporation Adamis Pharmaceuticals Corporation
ADMP
48.9 - 0.86 % $ 117 M usaUSA
Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc
AVDL
366 - 0.12 % $ 2.06 B franceFrance
Canopy Growth Corporation Canopy Growth Corporation
CGC
167 - -3.21 % $ 114 M canadaCanada
Cronos Group Cronos Group
CRON
221 - -1.32 % $ 1.35 B canadaCanada
Catalent Catalent
CTLT
71.9 - - $ 11.5 B usaUSA
DURECT Corporation DURECT Corporation
DRRX
460 - - $ 50.1 M usaUSA
Cumberland Pharmaceuticals Cumberland Pharmaceuticals
CPIX
239 - 1.17 % $ 55 M usaUSA
Eagle Pharmaceuticals Eagle Pharmaceuticals
EGRX
149 - -39.89 % $ 27.7 M usaUSA
Endo International plc Endo International plc
ENDP
100 - - $ 28.9 M irlandaIrlanda
HEXO Corp. HEXO Corp.
HEXO
703 - 2.45 % $ 38.1 M canadaCanada
Evoke Pharma Evoke Pharma
EVOK
995 - - $ 36.6 M usaUSA
Emergent BioSolutions Emergent BioSolutions
EBS
176 $ 11.07 - $ 567 M usaUSA
Athenex Athenex
ATNX
158 - -23.39 % $ 1.76 M usaUSA
Jupiter Wellness Jupiter Wellness
JUPW
59.7 - - $ 33.6 M usaUSA
Evolus Evolus
EOLS
50.3 $ 4.35 - $ 270 M usaUSA
China Pharma Holdings China Pharma Holdings
CPHI
168 - -2.39 % $ 11.4 M chinaChina
Harrow Health Harrow Health
HROW
80.1 $ 49.44 3.63 % $ 1.61 B usaUSA
OrganiGram Holdings OrganiGram Holdings
OGI
2.83 K $ 1.33 - $ 402 M canadaCanada
Lannett Company Lannett Company
LCI
127 - 1.15 % $ 7.11 M usaUSA
Bausch Health Companies Bausch Health Companies
BHC
172 - - $ 2.22 B canadaCanada
Pacira BioSciences Pacira BioSciences
PCRX
246 $ 21.69 2.05 % $ 1 B usaUSA
Perrigo Company plc Perrigo Company plc
PRGO
143 $ 14.49 0.59 % $ 1.99 B usaUSA
Organogenesis Holdings Organogenesis Holdings
ORGO
85.9 - -2.73 % $ 492 M usaUSA
PetIQ PetIQ
PETQ
64.9 - 1.64 % $ 400 M usaUSA
Aurora Cannabis Aurora Cannabis
ACB
1.35 K - -3.23 % $ 86.3 M canadaCanada
ProPhase Labs ProPhase Labs
PRPH
30.1 - - $ 5.07 M usaUSA
Radius Health Radius Health
RDUS
204 - - $ 1.42 B usaUSA
Recro Pharma Recro Pharma
REPH
49.1 - -4.76 % $ 65.3 M usaUSA
Rockwell Medical Rockwell Medical
RMTI
28.5 $ 1.08 -1.38 % $ 25.2 M usaUSA
OptiNose OptiNose
OPTN
370 - - $ 1.08 B usaUSA
cbdMD cbdMD
YCBD
165 $ 0.75 -6.86 % $ 3.23 M usaUSA
Assertio Holdings Assertio Holdings
ASRT
347 - 2.31 % $ 849 M usaUSA
PLx Pharma PLx Pharma
PLXP
97.2 - -27.8 % $ 2.56 M usaUSA
Sonoma Pharmaceuticals Sonoma Pharmaceuticals
SNOA
117 - - $ 3.52 M usaUSA
Veru Veru
VERU
179 - 3.03 % $ 321 M usaUSA
TherapeuticsMD TherapeuticsMD
TXMD
1.04 K $ 2.32 -2.52 % $ 24.2 M usaUSA
Viatris Viatris
VTRS
140 - - $ 19.4 B usaUSA